secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2026-05-14T20:03:27+00:00
Accession:  0001628280-26-035068
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus annual meeting elects two directors, ratifies auditor, approves say-on-pay frequency
--------------------------------------------------------------------------------

- Mary Szela and Gary Gordon elected to three-year director terms with ~92% for votes.
- Grant Thornton LLP ratified as independent auditor for fiscal 2026.
- Advisory vote on exec compensation approved; board adopts three-year frequency for future votes.
- Turnout: 67.9% of outstanding shares represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000162828026035068/0001628280-26-035068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000162828026035068/tlsi-20260514.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-035068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer